How much funding has Abogen Biosciences raised?

Abogen Biosciences has raised $1.3B in total funding, most recently a Extension Round.

Who are Abogen Biosciences's investors?

Abogen Biosciences's investors include SoftBank, 5Y Capital, GL Ventures, Temasek, Invesco Real Estate, PICC Capital Investment.

When was Abogen Biosciences founded?

Abogen Biosciences was founded in 2019.

Where is Abogen Biosciences headquartered?

Abogen Biosciences is headquartered in Suzhou, China.

What industry is Abogen Biosciences in?

Abogen Biosciences operates in Biotech, mRNA Therapeutics, Drug Discovery, Healthcare, Therapeutics.

How many employees does Abogen Biosciences have?

Abogen Biosciences has 201-500 employees.

Abogen Biosciences

formerly Abogen

Unlocking the mRNA technology for life-saving therapeutics

Suzhou, China · Founded 2019 · $1.3B raised

mRNA Therapeutics

Headquarters: Suzhou
Employees: 201–500
Founded: 2019
Business Model: B2B

Website: abogenbio.com
Total Funding: $1.3B
Last Round: $300.0M Extension RoundNov 2021
Rounds: 6

About

Abogen Biosciences is China's leading fully integrated mRNA medicines company, with proprietary platforms spanning mRNA sequence design, lipid nanoparticle (LNP) delivery, and scalable GMP manufacturing. Its Dynamic Precision Mixing (DPM) technology and ionizable lipid library have been validated in global Phase III trials enrolling 30,000+ participants. The company's pipeline spans immuno-oncology, autoimmune diseases, and infectious disease vaccines, with AI integrated across every development stage.

Summary

Abogen Biosciences is a Biotech company based in Suzhou, China, founded in 2019. It has raised $1.3B in total across 6 rounds, most recently a $300.0M Extension Round round in Nov 2021. Investors include SoftBank, 5Y Capital and GL Ventures.